tiprankstipranks
Trending News
More News >
Intellia Therapeutics (NTLA)
NASDAQ:NTLA
US Market
Advertisement

Intellia Therapeutics (NTLA) Technical Analysis

Compare
3,706 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
3Neutral
10Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Intellia Therapeutics’s (NTLA) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Intellia Therapeutics is a Buy.
Intellia Therapeutics’s (NTLA) 20-Day exponential moving average is 11.57, while Intellia Therapeutics’s (NTLA) share price is $10.86, making it a Sell.
Intellia Therapeutics’s (NTLA) 50-Day exponential moving average is 10.90, while Intellia Therapeutics’s (NTLA) share price is $10.86, making it a Sell.

Intellia Therapeutics (NTLA) Pivot Points

Aug 14, 2025, 12:11 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.07
10.33
10.54
10.80
11.01
11.27
11.48
Fibonacci
10.33
10.51
10.62
10.80
10.98
11.09
11.27
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Intellia Therapeutics (NTLA) Moving Averages

Aug 14, 2025, 12:11 AM
Period
Simple
Exponential
MA5
11.04Sell
11.06Sell
MA10
11.44Sell
11.40Sell
MA20
12.13Sell
11.57Sell
MA50
10.58Buy
10.90Sell
MA100
9.31Buy
10.58Buy
MA200
10.81Buy
12.37Sell
Intellia Therapeutics’s (NTLA) 10-Day exponential moving average is 11.40, while Intellia Therapeutics’s (NTLA) share price is $10.86, making it a Sell.
Intellia Therapeutics’s (NTLA) 100-Day exponential moving average is 10.58, while Intellia Therapeutics’s (NTLA) share price is $10.86, making it a Buy.
Intellia Therapeutics’s (NTLA) stock price is $10.86 and Intellia Therapeutics’s (NTLA) 50-day simple moving average is 10.58, creating a Buy signal.
Intellia Therapeutics’s (NTLA) stock price is $10.86 and Intellia Therapeutics’s (NTLA) 100-day simple moving average is 9.31, creating a Buy signal.
Intellia Therapeutics’s (NTLA) stock price is $10.86 and Intellia Therapeutics’s (NTLA) 200-day simple moving average is 10.81, creating a Buy signal.

Intellia Therapeutics (NTLA) Technical Indicators

Aug 14, 2025, 12:11 AM
Name
Value
Implied Action
RSI (14)
44.54
Neutral
STOCH (9,6)
10.64
Buy
STOCHRSI (14)
5.80
Buy
MACD (12,26)
<0.01
Buy
ADX (14)
22.48
Neutral
Williams %R
-92.27
Buy
CCI (14)
-106.72
Buy
ATR (14)
0.78
-
Ultimate Oscillator
45.31
Neutral
ROC
-23.74
Sell
Intellia Therapeutics’s (NTLA) Relative Strength Index (RSI) is 44.54, creating a Neutral signal.
Intellia Therapeutics’s (NTLA) Trend Strength Indicator (ADX) is 22.48, creating a Neutral signal.
Intellia Therapeutics’s (NTLA) Commodity Channel Index (CCI) is -106.72, creating a Buy signal.
Intellia Therapeutics’s (NTLA) Price Rate of Change (ROC) is -23.74, creating a Sell signal.

FAQ

Is NTLA a Buy, Hold, or Sell?
Based on NTLA’s technical indicators, NTLA is a Hold.
    What is NTLA’s RSI (14)?
    NTLA’s RSI (14) is 44.54, which suggests NTLA is a Neutral.
      What is NTLA’s MACD?
      NTLA’s MACD is <0.01, which suggests NTLA is a Buy.
        What is NTLA’s 5-day moving average?
        NTLA’s 5-day moving average is 11.04, which suggests NTLA is a Sell.
          What is NTLA’s 20-day moving average?
          NTLA 20-day moving average is 12.13, which suggests NTLA is a Sell.
            What is NTLA’s 50-day moving average?
            NTLA’s 50-day moving average is 10.58, which suggests NTLA is a Buy.
              What is NTLA’s 200-day moving average?
              NTLA’s 200-day moving average is 10.81, which suggests NTLA is a Buy.
                What is NTLA’s Williams % R (14)?
                NTLA’s Williams % R (14) is -92.27, which suggests NTLA is a Buy.
                  What is NTLA’s CCI (14)?
                  NTLA’s CCI (14) is -106.72, which suggests NTLA is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis